AI-powered search
Try Polaris, our new AI-powered search!

Which efficacy outcomes for topical roflumilast do you find most compelling and why?

Featuring Mark Lebwohl, MD | Senior Clinical Advisor |

Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology
Dean for Clinical Therapeutics at the Icahn School of Medicine, Mount Sinai
New York, NY

| Published August 30, 2022

Related Media

Powered by Polaris TM